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ABSTRACT
A nation's ability to innovate is paramount for its success and survival among other
nations. But capitalizing on these innovations and bringing them to the marketplace are
what gives a nation its competitive edge and provide sustainable growth over time in
this highly dynamic global economy. In the United States' complex innovation
ecosystem, small businesses and entrepreneurs play a crucial role in innovating new
technologies and commercializing them. Indeed many of the nation's large, successful
and innovative firms started out as small entrepreneurial firms. Microsoft, Intel, AMD,
FedEx, Qualcomm, Adobe are examples to these firms.
These small entrepreneurial firms with new ideas need to garner fair amount of funding
before they can bring their ideas into the marketplace. However for entrepreneurial
companies with science based innovative ideas, due to the unproven nature of these
ideas and the lack of sufficient public information, there exist knowledge asymmetries.
Therefore possibility of getting direct venture capital and/or angel investment becomes
very slim for these firms unless the idea's commercial potential is obviously clear or a
customer is already available. To address this early stage financing gap and to increase
private sector commercialization of innovations, the Federal government offers funding
through its three phase private-public partnership innovation program, called Small
Business Innovation Research (SBIR) program.
The purpose of this study is to investigate the existence of any correlations between
commercialization of SBIR funded projects, specifically Phase II programs, and various
characteristics of the involved entities in attempt to enhance commercialization
performance of an SBIR funded company. We hope that the results of this study will be
practical in defining commercialization strategies to achieve faster and stronger
capitalization on R&D investment for both the awarded company and the federal
government and hence the tax payers.
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1. INTRODUCTION
A nation's ability to innovate is paramount for its success and survival among other
nations. But capitalizing on these innovations and bringing them to the marketplace are
what gives a nation its competitive edge and provide sustainable growth over time in this
highly dynamic global economy. In the United States' complex innovation ecosystem,
small businesses and entrepreneurs play a crucial role in innovating new technologies and
commercializing them. Indeed many of the nation's large, successful and innovative
firms started out as small entrepreneurial firms. Microsoft, Intel, AMD, FedEx,
Qualcomm, Adobe are examples to these firms.
These small entrepreneurial firms with new ideas need to garner fair amount of funding1
before they can bring their ideas into the marketplace. However for entrepreneurial
companies with science based innovative ideas, due to the unproven nature of these ideas
and the lack of sufficient public information, there exists knowledge asymmetries
(Wessner, An Assessment of the Small Business Innovation Research Program, 2007).
such that the commercial potential of the innovation is only known to the person who
invented it and not to the potential investors. Therefore possibility of getting direct
venture capital and/or angel investment becomes very slim for these firms unless the
idea's commercial potential is obviously clear or a customer is already available. To
address this early stage financing gap and to increase private sector commercialization of
innovations, the Federal government offers funding through its three phase private-public
partnership innovation program, called Small Business Innovation Research (SBIR)
program. In addition to helping the small business firms pass the valley of death
(Wessner, SBIR and Phase III Challenge of Commercialization, 2007), by providing
early phase financing, the SBIR program also acts as a certification of promising new
Average investment by a venture capital firm is - and is changing over the past years. See Appendix for
further information.
technologies, encourages further private sector investment and increases visibility of the
company.
Since the inception of the SBIR program in 1982 the funding available to small
businesses kept increasing steadily, and with this increase came a stronger emphasis on
commercialization of SBIR funded technologies. To measure the commercialization
activities and the track record of the participants, the SBIR program office developed
several metrics. Commercialization achievement index (CAI) is one of these metrics
calculated based on the company commercialization report that is compiled by the
petitioning company. CAI is calculated based on companies' past commercialization
performance and is used during award selection process to evaluate competing awards in
terms of their potential for commercial application, and their expected benefits. Therefore
weak commercialization performance undermines a company's potential for an award
even though it may have a very strong technical case.
This increased emphasis on commercialization had a major impact on established SBIR
companies. These are companies that have historically captured a high percentage of the
awards but were focused on meeting the federal agency needs rather than bringing
products to the market place even though commercialization is a natural and logical
progression of SBIR program, as the companies only start making profits during this
phase, and not while receiving SBIR funding.
The purpose of this study is to investigate the existence of any correlations between
commercialization of SBIR funded projects, specifically Phase II programs, and various
characteristics of the involved entities in attempt to enhance commercialization
performance of an SBIR funded company. In this research we will focus on a privately
owned small business applied research and development company that is deemed one of
the nation's most successful 2 SBIR companies based on the number of Phase I and Phase
II projects awarded by various Federal agencies. The data set compiled for this research
2 There are only five companies that were awarded more than 125 Phase-II projects, and the company we
have selected is one of them. See the Appendix for Number of Phase-II programs per firm.
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includes more than 250 Phase II programs from the commercialization report filed by this
company. Due to privacy concerns the collected data as well as the name of the company
will be kept anonymous.
We believe commercialization is vital for both sustainable growth of a small business
company and its long term existence. Therefore our ultimate goal in this study is to try to
increase the commercialization activities in these types of businesses especially in SBIR
companies like the one we have studied in this research. We also hope that the results of
this study will be practical in defining commercialization strategies to achieve faster and
stronger capitalization on R&D investment for both the awarded company and the federal
government and hence the tax payers.
1.1. Background
The productivity slowdown in the United States in the early 1980s reduced the nation's
ability to compete economically in the global economy especially in steel and auto
manufacturing, and semiconductors industries. In light of this development, government
initiated several public policies to stimulate innovation and commercialize new
technologies. SBIR program was born as one of these public policy responses.
The SBIR program was created in 1982 by the Small Business Innovation Development
Act under the Regan Administration. As one of the nation's several innovation programs,
it is instituted to stimulate technological innovation among small private sector
businesses while providing government agencies new, cost effective technical and
scientific solutions to meet their diverse mission needs. This private public partnership
program offers competition based awards to provide early stage financial support for high
risk technologies with commercial potential.
The program is structured in three phases:
Phase I awards are funded for approximately 6 months and are up to $100,0003 .
This phase is considered as the start-up phase where the proof of concept study is
performed. The award winner uses the funding to execute a feasibility study to
establish the technical and commercial merits of the proposed idea. At the end of
this phase the funding Federal agency evaluates the idea and assesses the quality
of the firm, and makes the decision about consideration for further funding, which
is Phase II. Past data suggests that approximately 15 percent of SBIR participants
that apply receive a Phase I award (Wessner, An Assessment of the Small
Business Innovation Research Program, 2007).
3 $100,000 funding corresponds to around five hundred person hours in a small business company with
considerable overhead costs.
* Phase II awards are up to $750,0004 and last for as many as 2 years. This is the
research and development phase. Only the Phase I projects with most technical
and commercial potential move to this phase. The award winner develops a
prototype or a working model of his proposed concept. Concurrently, the program
investigator evaluates the commercial potential, performs market research and
identifies potential commercialization partners. Past data suggests that 40 percent
of Phase I winners reach this step.
* Phase III is the step where the commercialization happens. In this phase the
prototype developed in Phase II program transitions from a controlled
environment such as a laboratory to marketplace. There is no SBIR funding in this
phase and no time limitations. However data suggests that commercialization
usually happens in the first two years after Phase II completion (Wessner, An
Assessment of the Small Business Innovation Research Program, 2007). To
commercialize their product the small businesses are usually expected to find
additional funding thorough public or private sources. Depending on the state of
the product that is being developed the company could follow the following steps:
o Sell the product directly in the marketplace;
o Spin off as a separate entity;
o License their technology and collect royalties;
o Pursue follow-up production contracts issued by Federal agency;
o Seek for third party investment from venture funding or prime contractors
or private firms for further development;
o Apply for additional SBIR awards for related work;
o Apply for non SBIR research funding and contracts.
The three-phase structure of the SBIR program is illustrated also in Figure 1. As this
figure summarizes, in funding various high risk technical programs during Phase-I and
4 $750,000 Phase-II funding corresponds to approximately three thousand person hours after overhead costs
are included.
Phase-II of the SBIR program, the government expects to capitalize on its investment in
the form of tax revenue as a result of increased employment.
Figure 1: SBIR Program Structure
There is not a single recipe for successful transition from Phase IIto commercialization,
but usually if an idea has promising commercial potential, it attracts further investment to
help the company bring their product into the marketplace.
However, entrepreneurs and small businesses must meet the following eligibility criteria
to participate in the SBIR program:
American-owned and independently operated;
For-profit;
Principal researcher employed by business;
Company size limited to 500 employees.
The program currently mandates that all federal agencies with an external R&D budget
over $100 million annually set aside 2.5% of this money for awards to small businesses.
This requirement occasionally makes the funding agencies perceive this set-aside money
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as a tax on their budget (Wessner, An Assessment of the Small Business Innovation
Research Program, 2007), which as a result reduces the effectiveness of the program.
There are currently eleven federal agencies participating in this program, and they have
disbursed over $1.85 billion in year 2005. Of these eleven federal agencies, five are
administering over 96 percent of the program's funds as of year 2005. They are the
Department of Defense (DoD), the National Institute of Health (NIH), the Department of
Energy (DoE), the National Aeronautics and Space Administration (NASA), and the
National Science Foundation (NSF). These agencies support research using both grants
and contracts.
The program goals have not changed since it started in 1982. and are fourfold (Wessner,
An Assessment of the Small Business Innovation Research Program, 2007):
1) To stimulate technological innovation;
2) To use small business to meet Federal research and development needs;
3) To foster and encourage participation by minority and disadvantaged persons in
technological innovation; and
4) To increase private sector commercialization of innovations derived from Federal
research and development.
This program is especially advantageous for entrepreneurial small businesses, as the
funded firms retain the rights to intellectual property developed using SBIR award. There
are no royalties owed to the federal government. However, the government retains
royalty free use for a period.
The companies looking for funding from SBIR program go through a rigorous award
selection process. While every agency uses a different approach for selecting the most
promising idea, weight is put on the following points with descending order (U.S. Small
Business Administration Technology Resources Network, 2007):
* The soundness, technical merit, and innovation of the proposed approach and its
incremental progress toward topic or subtopic solution.
* The qualifications of the proposed principal/key investigators, supporting staff,
and consultants. Qualifications include not only the ability to perform the research
and development but also the ability to commercialize the results.
* The potential for commercial (government or private sector) application and the
benefits expected to accrue from this commercialization
Being a public private partnership, SBIR program involves several stakeholders. While
the dynamics of the SBIR ecosystem is fairly complex with interactions between several
entities, a simplified stakeholder diagram is presented in Figure 2. The small business
company is at the center of this ecosystem. Its primary stakeholders are the federal
agency funding the program, prime contractors, private sector firms and academic
institutions. The secondary ones are tax payers, venture capital firms, and federal
government.
Figure 2: SBIR Program Stakeholders
Motivation and Significance of Problem
There are two different motivations behind seeking a funding from SBIR program. First
one is product oriented, where the small business identifies a federal agency need that
aligns well with the company's competency, experience, and business model, and
responds to the opportunity with the objective of commercialization at the end of
program. The second one is more research oriented, where the small business focuses
more on solving the federal agency's need, than commercializing. The major difference
between the two is the difference in their priorities. The product-oriented approach gives
priority to commercialization and puts the goal of meeting federal agency needs as
secondary. Whereas research oriented approach gives priority to meeting federal agency
needs and hopes commercialization follows.
Product oriented small business are usually composed of a small number of people,
mainly focused on a product idea. Their ultimate goal in seeking funding from SBIR
program is to capitalize on their science based high technology idea as soon as possible
while protecting themselves from knowledge spillovers (Lerner, The Government as
Venture Capitalist: The Long-Run Impact of the SBIR Program, 1999). Therefore the
commercialization objective of the product oriented entrepreneurs and the SBIR program
overlap extensively. While the SBIR funding from Phase I and Phase II programs can
earn small businesses a fee in the order of 7% of the program money, they do not start
making profits until after they commercialize their product ideas. Only after then these
firms start realizing a return on investment. Therefore there is a very strong incentive for
these companies to turn their ideas into products through commercialization.
On the other hand, research oriented small businesses are usually well-established
companies with a long history of receiving SBIR funding. These companies' revenue
streams depend heavily on SBIR funds and their priority is mainly keeping the customer
[in this case the funding federal agency] happy by meeting their needs. While the work
done by these firms achieve the number one objective of SBIR program: meeting federal
-----
1.2.
agency needs, these firms have historically underemphasized the commercialization
objective of SBIR.
However, with the increased emphasis on commercialization during the award process,
there is also a great incentive for these research-oriented firms to commercialize their
product ideas.
In summary, both types of companies have strong incentives for commercialization:
1) Product oriented companies commercialize because this is where the money is;
2) Research oriented companies commercialize because otherwise they will be
negatively evaluated by the funding federal agency during award selection
process -unless they have an above average commercialization track record [kept
by the federal agency - CAI]
Therefore, an investigation of correlations between commercialization and various SBIR
program characteristics can reveal important facts that can then be used to develop
successful commercialization strategies. In this study we will focus on only research
oriented small business companies (#2).
Research Questions and Objectives
This research study evaluates the correlation between the commercialization success rate
and the following:
1) Experience 5 of the Principal Investigator;
2) Dollar amount of SBIR funding from Phase-I and Phase-II programs;
3) Dollar amount of investment received following the completion of the Phase-II
program from sources other than funding federal agency;
4) Reuse of knowledge gained from another SBIR or non-SBIR funded project;
5) Presence of a commercialization partner such as prime government contractor or
private sector firm at the beginning of the program.
The objectives of this study are summarized as follows:
1) To find correlation between commercialization success and various program
characteristics;
2) To make recommendations based on these findings.
5 In terms of number of years.
, - "- -
-
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1.3.
Literature Review
While much research has been done on commercialization of privately funded high
technology innovations, SBIR program, specifically commercialization of SBIR funded
programs, has attracted little interest from academia. Therefore the amount and variety of
publications on this topic are limited. The limitations on the collection and dissemination
of this highly proprietary data by the SBIR program office further limited the access to
research materials and discouraged any potential interest from academia.
For example, the paper "Bringing Science to Market: Commercializing from NIH SBIR
Awards" (Link & Ruhm, 2008) focused specifically on the management of the overall
SBIR program. It assessed the commercialization success of the SBIR program in general
for projects funded by NIH. This study statistically analyzes the SBIR program relative to
its stated objectives.
Another paper published on a relevant topic was "The effects of government-industry
R&D programs on private R&D: the case of the Small Business Innovation Research
program" (Wallsten, 2000). Scott Wallsten questioned the success of SBIR program in
achieving its objectives, and tried to answer if SBIR program actually increases
innovation activity.
The publication "When does Funding Research by Smaller Firms Bear Fruit?:Evidence
from the SBIR Program" (Gans & Stem, 2003) is another study published on the topic. In
this study, Gans & Stem quantitatively prove that project performance is highest for
SBIR projects in industrial segment which receive the most venture financing.
Research so far focused mainly on the management of the SBIR program and policy
recommendations to improve SBIR performance and it lacks the perspective from a
single company point of view. Our study hopes to fill this gap by providing a more
practical analysis of the SBIR program's commercialization aspect. It differs from the
23
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others in that it analyzes and examines commercialization in at one specific SBIR
company.
:i;
1.5. Thesis Flow
This study is organized in four chapters.
In Chapter 1 we outline the motivation behind this research, identify the research
questions we will be answering and include a brief literature review on the
commercialization of SBIR funded projects. In this chapter we also present a short
background on SBIR program.
In Chapter 2 we review the methodology used to evaluate the research questions
presented in Chapter 1. A short overview of the company from which we have collected
the data, will be given, and the data set we used to find the correlation between
commercialization and several program entities will be presented in detail. The key
assumptions we have made regarding the data will be highlighted.
In Chapter 3 we will step through the study results and analysis. We will present the
analysis procedure. We will regress several SBIR Phase II program parameters such as
experience of the Principal Investigator, existence of pre funding and involvement of
external commercialization partners from either private sector or from prime contractors
on commercialization success of these programs, and we will present the correlation
between these entities.
In Chapter 4 we present our findings, summarize the conclusions of this study and
provide recommendations for future work.
2. RESEARCH METHODOLOGY
In this chapter we will present the methodology we have adopted during this research
study. We will give background information about the participating company, and the
principal investigators. Then we will introduce the dataset we have compiled using the
company's commercialization report and the SBA Tech-Net database (DoD SBIR 09.1
Solicitation Instructions, 2009). Additionally we will explain the assumptions we made
during dataset compilation. Finally we will explain the steps we followed in putting
together the dataset.
2.1. Data Set
The data collected and analyzed in this study is from a small business company that uses
SBIR program funding for most of its commercialization activities. The company is
headquartered in Massachusetts and has an employee count of approximately 150,
composed of mainly scientists and engineers from various backgrounds. The company
has been in the contract research and technology development business for over 35 years
and serves both government and commercial customers. While the government funded
projects was its number one source of income during the early phases, there is now a
good balance between its commercial and government customers. Today SBIR funding
accounts for around 45% of its revenues and is in a declining trend. This is due to
increasing revenues realized from applied research performed for commercial customers
using technologies developed under SBIR program and commercialization of SBIR
programs in late eighties and early nineties. While these few early commercialization
successes helped the company generate revenues even to this day, sustainable revenue
growth is only achievable if the company can successfully commercialize more of the
Phase-II programs it receives, because continuous revenue stream from these early
commercialization hits will gradually diminish.
I:'
The dataset covers the Phase-II programs received by the company over the past twenty-
five years, since the first time it was awarded a Phase-II funding from the SBIR program
office in 1984. The total number of awards analyzed in this study is approximately two
hundred and fifty. Only Phase-II awards are considered, as these are the ones that result
in commercialization activities, receive investment and generate revenues. The
distribution of the number of awards received over this period is presented in Figure 3.
The award distribution reveals a strong positive overall trend with varying sizes of cyclic
behaviors. This could mainly be associated to the increased number employees.
1986 1991 1996 2001 2006
Years
Figure 3: Distribution of Number of Phase-H Awards Received by the Company since 1984
The two hundred and fifty Phase-II programs studied in this research were owned by
approximately eighty different principal investigators. This means some investigators had
more than one program.
These principal investigators had a diverse range of educational and professional
backgrounds. The distribution of their backgrounds is presented in Table 1. An important
point to note is that more than 80% of the Phase-II award winners had PhDs.
__ __
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Table 1: Distribution of Principal Investigator Background
Background Percentage
Chemistry 30%
Electrical Engineering 8%
Mechanical Engineering 7%
Aero/Astro 5 %
Other 15%
Similar to the principal investigator backgrounds, the U.S. federal agencies from which
the awards were received were also diverse. U.S. Air Force funded projects constitute
around 31% of the total, and represent the highest in the list almost twice as much as the
immediate follower. The distribution of all agencies that funded the Phase-II programs
over the past 25 years is presented in Figure 4.
35.0%
30.0%
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%
31.0%
12.1% 12.1%
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Figure 4: Distribution of Agencies for the Analyzed Phase-II Programs
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2.2. Procedures
The dataset, that we used to investigate the correlations between the commercialization
success and various program characteristics, was compiled from the following four
different sources:
1) Company commercialization report;
2) U.S. Small Business Administration Tech-NET database6
3) Company intranet;
4) Interviews with program investigators.
The company commercialization report is used to extract financial information regarding
the company's commercialization activities over the time of interest, which starts the year
the company is awarded its first Phase-II award. The report is proprietary, hence is not
publicly available. [Explain further the Company Commercialization Report]. The two
important key figures 1) Total sales amount and 2) Non-SBIR investment amount are
calculated for each Phase-II program, using the data presented in the report.
Total sales amount is one of the key variables and we will use it to assess the
commercialization success of the company during the analysis. This key variable is
calculated as the sum of the following five sale sources as reported in the
commercialization report:
1) Department of Defense and its prime contractors ;
2) Other Federal agencies;
3) Foreign countries (export);
4) Private sector;
6 Tech-Net is a web based search engine for researchers, scientists, state, federal and local government
officials. It provides resources and information for and about small high technology businesses, and works
as a bridge between these companies and potential investment sources.
7 Examples to prime contractors are Raytheon, Boeing etc.
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5) Anything other than the four above.
The report also includes additional investments other than the SBIR funding and breaks it
down further into the following four categories:
1) Investment from Department of Defense;
2) Investment from other Federal Agencies;
3) Investment from Private sector8;
4) And investment from other sources;
The non-SBIR investment amount is calculated by summing the investment under these
four categories for each Phase-II program in the report. This is also a key variable and it
will be used to investigate the relationship to the commercialization success of the
program.
As the data we are using in this study spans over 25 years, we normalized the sales and
investment values by converting them into present value of money. In doing so, we used
the Consumer Price Index (CPI) published by United States Dept of Labor, Bureau of
Labor Statistics.
After the data in the commercialization report is extracted, we looked at U.S. Small
Business Administration Tech-NET database to extract Phase-I and Phase-II program
funding. We searched for the Phase-II programs the company was awarded and cross-
referenced the topic numbers and identified the associated Phase-I and Phase-II funding.
We call the total of these two as SBIR funding amount, another key variable; the effect of
which we are investigating on the commercialization success of the program. The
maximum funding awarded by SBIR program to companies for Phase I and II has
remained constant since 1990, resulting in an erosion of value, and possibly affecting the
8 This includes venture capital and angel investments as well as prime contractor and private firm
investments.
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commercialization success, as some claim (Wessner, 2007). Through our investigation,
we are hoping to also put this hypothesis to test.
Furthermore we have extracted the name of the principal investigator from the database.
This information is then cross-referenced to PI information that is available from our
third source, the Company Intranet to estimate the experience level. This is another key
variable as our study investigates whether a correlation is evident between the experience
of the PI and the commercialization success. Quantifying a professional's relevant
experience to the program is neither straightforward nor easy. Hence we chose a
consistent view and calculated experience as the number of years working as a
professional (irrespective of whether the experience is relevant or not) since the
graduation date of the last institution the PIs graduated from.
As the final step of the data collection phase, we have personally interviewed several
principal investigators whose programs are included in the commercialization report. The
interviews were conducted to gather qualitative data and to address the following specific
questions:
1. If knowledge gained from another SBIR or non-SBIR funded project is utilized in their
current projects,
2. If a commercialization partner such as prime contractor or private sector firm was
identified at the beginning of the Phase II.
While we conducted the interviews for qualitative data, we chose to ask only questions
that can be answered with a "yes" or "no" (i.e. dichotomous) to keep data reliability to a
maximum.
At its final stage the completed dataset included the key information shown in Table 2.
Variable Name
Phase-II Award Ye
Total SBIR Fundin
Total Sales Amoun
Additional non-SB
Previ Work Expelien
Previous Knowled
Presence of Comm
Table 2: Collected Data and its Range
Range
!ar 1985-2005
Lg $200,000 to $2,000,000
$0 to $21,000,000
IR Investment $0 to $19,000,000
6 e 2 to 38 years
ge Utilized9  Yes or No
ercialization Partners Yes or No
2.3. Assumptions
Assumption #1
The effect of inflation on all monetary variables was taken into account during this study
since the data set applies to two and a half decades of time. Instead of applying the CPI
index for every individual year, we used the average (3.9%) over the same period as
published by Dept. of Labor. The actual versus the average CPI index is presented in
Figure 5.
9 Answer is yes or no (dichotomous).
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Figure 5: CPI and Average CPI from 1985 to 2007
Assumption #2
In the company commercialization report, total sales amount for each program is listed as
a lump sum instead of being broken down by the years in which the revenue was
materialized. To normalize the effect of time on this key variable, we made the following
assumptions in our calculations:
* All of the sales revenue is materialized within five years of Phase II completion.
Five years is chosen as it usually represents an average life-cycle for a high-tech,
cutting edge product
* The sales revenue is equally distributed among the assumed five years of
commercialization.
)-- --------  - ------------- ---------
.. ...... . ........ . . .
. . . . . .. .
... .........
Sales revenue starts to materialize within three years after completion of Phase II
program.
Assumption #3
Approximately 2% of the data queried in Tech Net database did not return any results for
SBIR funding. However, this data contained invaluable commercialization information
and hence we didn't omit the whole record. Instead, we used the average SBIR funding
for that specific year across all projects to estimate the missing SBIR funding amount.
Assumption #4
Although the dataset covers up to and including year 2008, we have only considered data
for projects up to 2006. We believe the commercialization data for more recent projects
would be incomplete and that using such data would skew our results. Thus we omitted
projects starting after 2005.
Assumption #5
Considering the length of time our dataset covers, we were not able to interview every PI.
Thus we have filled in the gaps of information with:
* Discussions with respective area managers;
* Interpolating from other projects based on similarity to other programs;
* Based on our self-assessment of the program.
3. ANALYSIS and STUDY RESULTS
In the previous chapter we have laid down the groundwork for the data and presented the
methodology. And in this chapter we will analyze the data set that we have collected and
combined from several different resources and present the study results.
Throughout this chapter commercialization success will be our main metric, and we will
evaluate the correlation between this metric and the following:
1. Experience of the Principal Investigator;
2. Dollar amount of SBIR funding from Phase-I and Phase-II programs;
3. Dollar amount of investment received following the completion of the Phase-II
program from sources other than funding federal agency;
4. Reuse of knowledge gained from another SBIR or non-SBIR funded project
5. Presence of a commercialization partner such as prime government contractor or
private sector firm at the beginning of the program.
Commercialization is an open ended concept and needs to be defined and quantified in
the context of our analysis. We evaluate commercialization success based on the
revenues generated following completion of Phase II program. To eliminate outliers, we
defined a threshold of 10 percentile of the revenue stream. To calculate the sales amount
that corresponds to 10 percentile threshold we plot the total sales revenue distribution,
including the programs that have generated sales. The result is illustrated in Figure 6.
This plot can be considered as the cumulative distribution function of the sales revenue
where x-axis represents the sales revenue, and the y-axis represents the percentage of
programs having sales revenue up to that point. Since the distribution is heavily skewed,
a zoomed-in version is presented in Figure 7; showing that the 10 percentile point
corresponds to approximately $25,000 total sales amount. Throughout this study, we will
only consider those programs with higher than $25,000 total sales revenue as
commercially successful. Using this type of dollar threshold simplifies the evaluations by
allowing us define the commercialization success as a dichotomous variable.
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Figure 6: Distribution of Sales Revenue - Cumulative Distribution Function
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Figure 7: Distribution of Sales Revenue - Cumulative Distribution Function (Zoomed-In)
Experience of Principal Investigator
We calculated the experience of the principal investigator at the time Phase II was
awarded for each commercially successful project to identify the existence of a
correlation between principal investigator experience and commercialization success.
The resulting plot is presented below in Figure 8. While the experience distribution is
skewed towards 8 years, there is no obvious correlation between the commercial success
of a Phase II program and the experience level of its principal investigator. The skewing
may be attributable to the fact that the company employed more people with this amount
of experience.
s
...................................................................... .............................................................f i/I ;
vi
5 10 15 20 25 30
Principal Investigator Experience
in years
35 40
Figure 8: Relationship between Principal Investigator Experience and Commercialization
Thus we shifted our focus to another possible parameter instead of principal investigator
experience. We've looked at each individual principal investigator and calculated the
number of Phase II programs he/she worked on before achieving the first commercially
successful Phase II program. The resulting plot is presented in Figure 9. It is obvious
from this analysis that the majority of principal investigators worked on at least one
Phase II program before they achieved their first program with revenues of higher than
$25,000.
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Figure 9: Number of SBIR Ph-II Programs the Principal Investigator Works on Before Achieving
Commercialization Success
This result is expected since the principal investigator builds up not only technical
knowledge from the first Phase II program, but also an understanding of the SBIR
funding eco-system, expectations of Federal Agencies and develops contacts from the
first one. Based on this finding we suggest developing a mentorship program to
accelerate the acquisition of this knowledge and experience or compensate for lack of it.
SBIR funding from Phase-I and Phase-II programs
The next parameter we looked into is the amount of SBIR funding from Phase I and II
programs combined. For this analysis, we considered the whole data set and created a
dichotomous variable for commercialization status where the number one (1) indicates
commercially successful (total sales revenue>=$25,000) programs and number zero (0)
indicates the opposite where revenues are less than $25,000. We then plotted the amount
of SBIR funding received for these programs. We used the present value of the funding
amounts to be able to fairly compare programs. This plot is shown in Figure 10. It
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suggests that for the data set under investigation, there is no evident correlation between
the commercialization status of a Phase II program and the total amount of SBIR funding
the program receives. However, this doesn't mean that there is no correlation at all. We
would suggest expanding the data set to other companies and re-evaluating the
correlation results.
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Figure 10: Relationship between SBIR Funding Amount and Commercialization
In this analysis, we used a monetary parameter, mainly because our data set consists of
one company's data. However, a better metric that can be used for the analysis of an
expanded data set with multiple companies would be man-hours. This would normalize
the differences among rates charged by different companies, accounting for differences
not only for direct labor and materials but also overhead and administrative costs.
Investment received from sources other than funding federal agency
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Another significant parameter we studied is the investment received from non-SBIR
sources including from Department of Defense, other Federal Agencies, Private sector
and other sources. For this analysis, we considered the whole data set and created a
dichotomous variable for commercialization status where the number one (1) indicates
commercially successful (total sales revenue>=$25,000) programs and number zero (0)
indicates the opposite where revenues are less than $25,000. We then plotted the net
present value of investment received from all sources other than the funding federal
agency for these programs. This plot is shown in Figure 11. As the Figure indicates,
programs that attract an additional investment of over $400,000 have a higher chance of
achieving commercialization success.
0
Investment received from sources other than funding
federal agency
Figure 11: Relationship between non-SBIR Investment and Commercialization
However, whether the additional investment increases the chance of commercialization
or if the commercialization potential of the project attracts additional investment cannot
be deduced from the data set we have available. But commonsense and our finding
suggest that additional investment backed up by a sound technical idea definitely
increases commercialization. Therefore identifying potential users of the product allows
us to find out the potential investment sources early in the program and develop the
program with an emphasis on commercialization.
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Reuse of knowledge gained from another SBIR or non-SBIR funded
project
Another factor we investigated in determining commercialization success is the possible
reuse of knowledge gained from another SBIR or non-SBIR funded project. This factor
is especially important since the main objective of any research and development project
is the accumulation of particular knowledge to be used in an application or to be the basis
of further research. Thus it's only logical to expect that reuse of knowledge should
increase chances of commercialization.
We compiled our findings from our interviews about the reuse of knowledge gained from
another SBIR or non-SBIR funded project in relation to commercialization success in
Figure 12. Based on our findings, only 30% of the programs reused knowledge. While
the statistical significance of this sample is a topic of discussion in itself, for the purposes
of this study we will interpret the result as is.
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Failure Success
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Figure 12: Relationship between Knowledge Reuse and Commercialization
The results presented show that:
* 10% of projects in which knowledge was reused failed to commercialize, while
20% of projects in which knowledge was reused commercialized.
* 50% of projects in which knowledge was not reused failed to commercialize,
while 20% of projects in which knowledge was not reused commercialized.
Out of the projects that knowledge was reused, two thirds commercialized, while this
ratio was only one third for the projects that have not reused knowledge. While on the
surface this would indicate a positive correlation, we would be cautious to do so due to
the limited sample population of projects that reused knowledge.Fai~~z~- ~ Suc~I
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Another important observation is the negative correlation between lack of knowledge
reuse and commercialization. Of all the projects that we investigated, half did not reuse
any knowledge and failed to commercialize.
Presence of a commercialization partner
Another factor we investigated in determining commercialization success is the presence
of a commercialization partner. Usually in projects of this nature the commercialization
partner - if exists - either is directly linked to the user or has great familiarity with the
end user. Most of the time, the end user is not the funding agency, funding agencies are
merely enablers. Therefore having a commercialization partner enables a greater focus on
customer needs and satisfaction rather than only on satisfying funding agencies' needs.
We present our findings about the presence of a commercialization partner in relation to
commercialization success in Figure 13.
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Figure 13: Relationship between Commercialization Partner Presence and Commercialization
The results presented show that:
* 60% of projects had a commercialization partner.
* 35% of projects with a partner failed to commercialize, while 25% of projects
with a partner commercialized.
* 25% of projects without a partner failed to commercialize, while 15% of projects
without a partner commercialized.
Of the projects that have commercialized 63% had a commercialization partner. This
shows that the chances of commercialization increase if there is a partner with strong
commercialization interest in the project. Also, 35% of all the projects didn't have a
commercialization partner and they failed to commercialize. This strengthens our
argument that commercialization is positively correlated to having a commercialization
partner helps.
4. CONCLUSIONS
In this study we have evaluated the effects of the following factors on the
commercialization success of a small business company competing for SBIR funding:
1. Experience of the Principal Investigator;
2. Dollar amount of SBIR funding from Phase-I and Phase-II programs;
3. Dollar amount of investment received following the completion of the Phase-II
program from sources other than funding federal agency;
4. Reuse of knowledge gained from another SBIR or non-SBIR funded project
5. Presence of a commercialization partner such as prime government contractor or
private sector firm at the beginning of the program.
Throughout this study we have defined an SBIR program as commercially successful if it
had generated sales revenue greater than or equal to $25,000 following the completion of
the SBIR Phase-II program. The following chapter summarizes the findings of our study.
4.1. Conclusions
Experience of Principal Investigator
There is no correlation between the experience of the principal investigator and the
commercialization success of the program. Even though the results revealed some skew
in the experience of investigator, this could very well be because of the fact that the
company may have employed more people with this amount of experience during that
time period.
However further investigation of the number of SBIR Ph-II programs the principal
investigator worked on before achieving a commercialization success, showed that there
is a strong correlation between this factor and commercialization success of the program.
The results revealed that for more than 65% of principal investigators who have
successfully commercialized, it took at least one Phase II program before they achieved
their success.
We tie this result to the fact that SBIR ecosystem with its large number of stakeholders is
fairly complex, and it takes some time for the principal investigator to establish an
understanding of this system, understand expectations of Federal Agencies and develop
internal and external contacts. Based on this finding we suggest developing a mentorship
program to accelerate the acquisition of this knowledge and experience or compensate for
lack of it.
SBIR funding from Phase-I and Phase-II programs
The investigation of effects of SBIR funding from Phase-I and Phase-II programs, on
commercialization success of a program has revealed no correlation between them.
However, this doesn't mean that the funding amount has no effect at all; it merely
suggests that for the technologies the company is working on, the SBIR funding is large
enough that it has no effect on commercialization. Further increase of the existing
funding amount dramatically however could very well increase the commercialization
percentage.
We would suggest expanding the data set to other companies and re-evaluating the
correlation results using a better metric such as man-hours rather than monetary values in
assessing the effects to normalize the differences among rates charged by different
companies, accounting for differences not only for direct labor and materials but also
overhead and administrative costs.
Investment received from sources other than funding federal agency
We have found that investment received from sources other than funding federal agency
has positive impact on commercialization such that programs that attract an additional
investment of over $400,000 have a higher chance of achieving commercialization
success.
However, whether the additional investment increases the chance of commercialization
or if the commercialization potential of the project attracts additional investment cannot
be deduced from the data set we have available. So we suggest conducting a further
investigation using a larger dataset from several different SBIR companies.
Reuse of knowledge gained from another SBIR or non-SBIR funded
project
Study of relations between the reuse of knowledge gained from another SBIR or non-
SBIR funded project and the commercialization success of that project did not reveal any
strong correlation between these two. Among the projects that achieved
commercialization, the percentage of the ones that reused knowledge is approximately
same as the ones that have not, therefore a definite correlation cannot be deduced.
However we believe there is a negative correlation between lack of knowledge reuse and
commercialization. Of all the projects that we investigated, half did not reuse any
knowledge and failed to commercialize.
Presence of a commercialization partner
Another important finding was that the presence of a commercialization partner definitely
helps. Given that the program is commercially successful, the chance of this project
having a commercialization partner is twice higher than not having.
Due to the limitations in the data collected, however we would be cautious to say that it is
directly a consequence of actually having a commercialization partner, there might be
another underlying factor that affects the outcome.
4.2. Future Work
In this study we have focused our efforts only on a single SBIR company. Due to the
proprietary nature of the data needed for this research, access to this data was of
uttermost concern. While we believe the projects conducted by this company represent a
significant sample of the SBIR program population in general in terms of breath and
depth of the program, we strongly believe further investigation with emphasis on more
diversity with consideration of additional factors (variables) could prove useful for a
wider target audience. The results of such a study can be used by;
1) SBIR program office: For guidance of funded companies in commercializing
their technologies in minimum amount of time, with minimum amount of effort,
and also gauging the effectiveness of the SBIR program as a whole in terms of
satisfying one of the most important objectives - commercialization.
2) SBIR companies petitioning for R&D funding: For identifying the major
drivers for commercialization of high technology ideas and understating their
effect.
3) Entrepreneurs: In gauging possibilities of obtaining government funding for
commercializing their product ideas.
Such a study will no doubt require high concurrence from the government in terms of
collecting the invaluable data in a format without affecting the competitive advantage of
companies seeking SBIR funding - probably by either aggregating or anonymizing the
data. This type of effort will require also identifying several more different variables. The
decision on these variables will require revisiting the objectives of the study, and the
expectations of the target audience.
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Figure 14: Number of Phase-II Programs per Firm
Geographical distribution of Phase-I and Phase-II awards received since the inception of
the SBIR program until 2005, reveals that top two states; California and Massachusetts
capture more than one third of the program budget. This could be associated to the fact
that the close proximity of these states to high technology firms, venture capital and angel
networks, as well as to highly innovative academic institutions.
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Figure 15: Geographical distribution of Phase-I SBIR Awards
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Figure 16: Geographical distribution of Phase-II SBIR Awards
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Appendix 2
Table 3: Excerpt from the compiled data-set
o1,183, Co44
merci m era
Total PI alizati Know aizati
Funding Total Exp on ledge onPh-I Ph-] Ph4l Ph-Il (Present Agen Total invest erie Succe feus PartnYear funding Year Funding Value) cy Sales ments nce ss ed er
$1,183,44
2006 $99,986 2007 $999,964 5 MDA $0 $0 5 0 0 1
$1,360,33 $1,436,5
1986 $50,000 1987 $630,300 2 DARPA 86 $0 7 1 1 1
1997 $59,963 1999 $486,960 $750,769 Navy $0 $66,364 19 0 0 0
1999 $90,000 2000 $224,990 $398,205 EPA $0 $3,907 5 0 1 0
$1,025,87
2000 $99,922 2001 $700,000 3 DOE $0 $17,250 6 0 0 0
$122,70
2004 $69,988 2005 $224,877 $328,625 EPA 4 $0 10 1 0 0
2005 $99,989 2006 $749,954 $932,890 OSD $0 $0 15 0 0 0
$1,172,35
2006 $99,975 2007 $999,945 5 MDA $0 $0 16 0 0 0
2004 $69,847 2005 $599,797 $759,689 NASA $0 $0 13 0 1 0
$1,166,13 $140,45
2004 $179,577 2006 $888,309 5 HHS 0 $54,683 14 1 0 0
2007 $299,980 2008 $594,244 $915,371 NIH $0 $0 16 0 0 0
2007 $99,980 2008 $749,888 $876,554 AF $0 $0 12 0 0 0
$199,95
2005 $99,851 2006 $749,882 $932,672 DOE 6 $19,589 8 1 1 0
2005 $69,923 2007 $499,992 $606,134 Navy $74,781 $94 9 1 0 0
